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Mast cells regulate both inflammatory responses and tissue
repair in human diseases but there are conflicting reports on
the role of these cells in the pathogenesis of various kidney
diseases. Here we measured mast cell function in unilateral
ureteral obstruction, a well-characterized model of renal
fibrosis, using KitW/KitWv mice genetically deficient in mast
cells, wild-type mice, and deficient mice reconstituted by
adoptive transfer with mast cells from the wild-type animals.
Mast cell-deficient mice had higher levels of renal tubular
damage, more stromal fibrosis, higher numbers of infiltrating
ERHR3-positive macrophages and CD3-positive T cells,
and higher tissue levels of profibrotic transforming growth
factor-b1 than wild-type mice or mice reconstituted by
adoptive transfer of mast cells 3 weeks after ureteral
obstruction. Similarly, while wild-type and adoptively
transferred mice had increased a-smooth muscle actin and
decreased E-cadherin expression, which are indicators of
epithelial-mesenchymal transition, the obstructed kidneys of
the mast cell–deficient mice had significant attenuation of
those indicators. Thus, our study suggests that mast cells
protect the kidney against fibrosis by modulation of
inflammatory cell infiltration and by transforming growth
factor-b1-driven epithelial-to-mesenchymal transitions.
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Mast cells (MCs) have important roles in innate and adaptive
immunity.1 The numbers of MCs increase at the sites of
tissue injury and inflammation.2 After activation, MCs
secrete various mediators, cytokines, and growth factors that
mediate vascular permeability, inflammation, chemotaxis,
and tissue destruction or tissue protection.3,4 MCs have been
associated with conditions of persistent inflammation, such
as multiple sclerosis,5 rheumatoid arthritis,6 inflammatory
bowel disease,7 and ischemia-reperfusion injury.8 Thus, MCs
regulate both inflammatory responses and tissue repair in
human diseases.9
The numbers of MCs in the kidney increase in various
human renal diseases, such as diabetic nephropathy,10 IgA
nephropathy,11 rapid progressive glomerulonephritis,12 me-
sangial proliferative glomerulonephritis,13 and acute rejec-
tion.14 Experimental renal disease models have suggested that
MCs may contribute to the progression of renal disease.9,15
Jones et al.15 showed that MC infiltration may contribute to
progressive renal injury in the 5/6 nephrectomy model.
Timoshanko et al.9 suggested that renal MCs can mediate
crescentic glomerulonephritis by regulating adhesion mole-
cules. In contrast, Miyazawa et al.16 suggested that MCs
might have a protective role in puromycin aminonucleoside-
induced nephrosis. Thus, there are conflicting data about the
role of MCs in the pathogenesis of renal disease.
Obstructive uropathy is an important cause of end-stage
renal disease in infants and adults. Most forms of chronic
renal disease progress to tubulointerstitial fibrosis, which is
one of the major characteristics of obstructive nephropathy
and correlates with a loss of renal function. In fact, the
severity of tubulointerstitial changes is the best indicator of
the progression of renal dysfunction.17,18
Mouse unilateral ureteral obstruction (UUO) has been
used as a model of renal interstitial fibrosis, but the role of
MCs in the UUO model has not been studied. To determine
the influence of MCs on the tubulointerstitial fibrosis
induced by UUO, we used MC-deficient WBB6F1-Kit
W/
KitWv (KitW/KitWv) mice to evaluate whether MCs have a
protective effect on renal interstitial fibrosis. We found that
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MCs suppress the renal fibrotic processes and type I collagen
deposition triggered by UUO. MCs decreased the number of
ERHR3- and CD3-positive cells infiltrating the kidney tissue
and the tissue level of transforming growth factor (TGF)-b1
in the UUO model. In an immunoblotting analysis, MCs also
inhibited the expression of a-smooth muscle actin (a-SMA)
and preserved the expression of E-cadherin in the obstructed
kidneys. These findings indicate that MCs may have a
beneficial effect on interstitial fibrosis in the UUO model.
RESULTS
MCs in sham-operated and obstructed kidneys
To identify renal MCs in sham-operated or obstructed
kidneys in congenic wild-type WBB6F1-Kit
þ /þ (Kitþ /þ )
and MC-reconstituted KitW/KitWv mice, we stained serial
kidney sections with toluidine blue and an anti-tryptase
antibody. Nearly all toluidine blue-stained MCs showed
positive immunostaining for tryptase in kidneys from Kitþ /þ
and MC-reconstituted KitW/KitWv mice (Supplementary
Figure 1a and b). Three weeks after UUO, the number of
toluidine blue-positive and tryptase-positive MCs was higher
in the obstructed kidneys of Kitþ /þ mice (0.5±0.1/mm2)
than in the kidneys of sham-operated mice (0.1±0.1/mm2;
Po0.025). No MCs were identified in the obstructed kidneys
of the KitW/KitWv mice. In contrast, a substantial number of
toluidine blue-positive and tryptase-positive MCs had
infiltrated the obstructed kidneys of MC-reconstituted
KitW/KitWv mice (0.4±0.1/mm2). The number of toluidine
blue-positive and tryptase-positive MCs in sham-operated
kidneys of MC-reconstituted KitW/KitWv mice was
0.08±0.05/mm2. MCs were observed in the interstitium
with a scattered distribution.
Protective effects of MCs on morphology in UUO
To determine the degree of tubular injury in the renal cortex
of obstructed and sham-operated kidneys, we used three
parameters: tubular dilatation, epithelial desquamation, and
brush border loss. Three weeks after UUO, the obstructed
kidneys of Kitþ /þ mice showed destruction of the renal
tubules with significant mononuclear inflammatory infiltra-
tion and severe stromal fibrosis (Figure 1a and b). The
obstructed kidneys of KitW/KitWv mice showed relatively
more damage to the renal tubular structure, more stromal
fibrosis, and more inflammatory cell infiltration than those of
Kitþ /þ mice (Figure 1c). The obstructed kidneys of MC-
reconstituted KitW/KitWv mice showed fewer destructive
changes to the renal tubular structure and less stromal
fibrosis and stromal inflammatory cell infiltration than those
of KitW/KitWv mice (Figure 1d). The histological findings
were supported by the semiquantitative histological score
(Figure 1e). To evaluate the effect of UUO on kidney
function, we measured the serum creatinine level in Kitþ /þ
and KitW/KitWv mice. The serum levels of creatinine were
not significantly different between Kitþ /þ and KitW/KitWv
mice 3 weeks after UUO (0.32±0.05 mg/100 ml in Kitþ /þ
mice; 0.35±0.04 mg/100 ml in KitW/KitWv mice; n¼ 5 in
each group). Thus, these data show that MCs protect against
tubulointerstitial histologic damage after UUO.
UUO-induced renal fibrosis is ameliorated by MCs
To determine the effect of MCs on interstitial fibrosis in
UUO, we stained slides with Masson’s trichrome and
measured the deposition of blue-stained collagen. No fibrosis
was observed in sham-operated kidneys in Kitþ /þ mice
(Figure 2a). Collagen deposition was significantly higher in
the obstructed kidneys of Kitþ /þ mice than in sham-operated
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Figure 1 | MCs decrease renal tubulointerstitial damage after
UUO. Formalin-fixed renal tissues were embedded in paraffin,
cut into 5-mm sections, and stained with hematoxylin–eosin. (a–d)
Representative pictures of tubulointerstitial lesions with
glomeruli. Three weeks after UUO, more inflammatory cell
infiltration, tubular atrophy, and interstitial fibrosis were observed
in KitW/KitWv mice than in Kitþ /þ mice. In contrast, such lesions
were significantly reduced in MC-reconstituted KitW/KitWv mice.
Bar¼ 50mm. (e) Semiquantitative scoring of tubular injury after
UUO revealed more damage in KitW/KitWv mice; n¼ 6–8 for each
experimental group. Data are expressed as means±s.d. *Po0.025
compared with UUO kidneys from Kitþ /þ mice; wPo0.025
compared with UUO kidneys from KitW/KitWv mice. Kitþ /þ ,
congenic wild-type WBB6F1-Kit
þ /þ mice; KitW/KitWv,
MC-deficient WBB6F1-Kit
W/KitWv mice; MC, mast cell; Sham,
sham-operated mice; UUO, unilateral uretal obstruction.
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mice 1, 2, and 3 weeks after UUO (Figure 2b). However,
there were no significant differences in collagen deposition in
the obstructed kidneys of Kitþ /þ and KitW/KitWv mice 1
or 2 weeks after ureteral obstruction (data not shown). At 3
weeks, collagen deposition increased 1.5-fold
in KitW/KitWv kidneys compared with Kitþ /þ kidneys
(Figure 2c and e). The reconstitution of MCs in KitW/KitWv
mice reversed the increase in interstitial renal fibrosis seen
in the mice by approximately 60% (Figure 2d and e).
Interstitial type I collagen expression in UUO kidneys in
KitW/KitWv mice was 1.4-fold higher than that in Kitþ /þ
mice. Reconstitution of MCs in KitW/KitWv mice reduced
this increase in the deposition of interstitial type I collagen in
kidneys by 44% (Figure 2f).
Increased infiltration of ERHR3-positive macrophages and
CD3-positive T cells in kidneys of KitW/KitWv mice
The numbers of ERHR3-positive monocytes/macrophages
per unit area in KitW/KitWv mouse kidneys were 1.5-fold
higher than in kidneys from Kitþ /þ mice 2 and 3 weeks after
UUO (Figure 3i). Reconstitution of MCs in KitW/KitWv
mice reduced this increase in the numbers of ERHR3-positive
cells per unit area in kidneys by 90 and 60% at 2 and 3 weeks
after UUO (Figure 3i). However, the numbers of ERHR3-
positive macrophages were not significantly changed in KitW/
KitWv kidneys 1 week after UUO.
The numbers of CD3-positive T cells per unit area in
KitW/ KitWv mouse kidneys were 3.3-fold, 1.6-fold, and 2.4-
fold higher than in kidneys from Kitþ /þ mice 1, 2, and 3
weeks after UUO (Figure 3j). Reconstitution of MCs in KitW/
KitWv mice reduced this increase in the numbers of CD3-
positive T cells per unit area by 96 and 85% at 2 and 3 weeks
after UUO (Figure 3j). Thus, the presence of MCs decreased
the infiltration of monocytes/macrophages and CD3-positive
T cells into UUO kidneys 2 and 3 weeks after UUO.
Changes in renal TGF-b1, Smad 2/3, and Smad 7 in
KitW/KitWv mice and MC-reconstituted KitW/KitWv mice
TGF-b1, Smad 2/3, and Smad 7 have pivotal roles in renal
fibrosis in UUO.19 The tissue levels of TGF-b1 mRNA
measured by real-time PCR were significantly higher in
kidneys from KitW/KitWv mice than in kidneys from Kitþ /þ
mice 3 weeks after ureteral obstruction (Figure 4a). The TGF-
b1 mRNA level in kidneys from MC-reconstituted KitW/
KitWv mice was significantly lower than in kidneys from
KitW/KitWv mice. Three weeks after ureteral obstruction, the
tissue levels of active TGF-b1 were significantly increased in
kidneys from KitW/KitWv mice compared with those from
Kitþ /þ mice as assessed by enzyme-linked immunosorbent
assay (Figure 4b). Reconstitution of MCs in KitW/KitWv
mice significantly reversed the increase in tissue TGF-b1 level
at 3 weeks after ureteral obstruction down to that seen in
Kitþ /þ mice. These data suggest that MCs have a role in
decreasing the tissue TGF-b1 level in the UUO mouse model.
Downregulation of Smad 2/3 is associated with attenuated
renal fibrosis in the UUO model, and Smad 7 negatively
regulates renal fibrosis by inhibiting Smad 2/3 activation in
vivo.20,21 Immunoblots of Smad 2/3 showed that renal Smad
2/3 was 1.4-fold higher in the obstructed kidneys of KitW/
KitWv mice than in those of Kitþ /þ mice (Figure 4c). Smad
2/3 was approximately 66% lower in kidneys from MC-
reconstituted KitW/KitWv mice 3 weeks after UUO than in
UUO kidneys from KitW/KitWv mice (Figure 4c). After 3
weeks, Smad 7 was approximately 46% lower in UUO
kidneys from KitW/KitWv mice than in UUO kidneys from
Kitþ /þ mice. Smad 7 in kidneys from MC-reconstituted
KitW/KitWv mice increased approximately 1.3-fold com-
pared with kidneys from KitW/KitWv mice (Figure 4d).
These results suggest that MCs restored the UUO-induced
levels of Smad 2/3 and Smad 7 to the levels seen in Kitþ /þ
mice.
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Figure 2 | MCs reduce renal interstitial fibrosis and type I
collagen deposition in UUO kidneys. (a–d) Light-field
photomicrographs of Masson’s trichrome–stained sections of
sham-operated and UUO kidneys at 3 weeks after surgery.
Collagen is visible as the blue stain. Bar¼ 50 mm. (e) Percentage of
area of tubulointerstitial fibrosis in Masson’s trichrome–stained
sections. Eight randomly selected high-power fields were
quantified and averaged to obtain the value for each animal;
n¼ 6–8 for each experimental group. (f) Percentage of area of
type I collagen in the sham-operated and UUO kidneys 3 weeks
after surgery. Bar graph shows the percentage of the positively
stained area relative to the total field. n¼ 6–8 for each
experimental group. Data are expressed as mean±s.d. *Po0.025
compared with UUO kidneys from Kitþ /þ mice; wPo0.025
compared with UUO kidneys from KitW/KitWv mice. Kitþ /þ ,
congenic wild-type WBB6F1-Kit
þ /þ mice; KitW/KitWv, MC-deficient
WBB6F1-Kit
W/KitWv mice; Sham, sham-operated mice.
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MCs preserve E-cadherin and inhibit a-SMA expression
Because TGF-b1 has an important regulatory role in the
epithelial-to-mesenchymal transition (EMT) in renal fibrosis,
and the epithelial adhesion receptor E-cadherin and a-SMA
are the molecular hallmarks of EMT, we next examined the
effects of MCs on the expression of E-cadherin and a-SMA.
Ureteral obstruction in KitW/KitWv mice suppressed E-
cadherin by approximately 55% and dramatically increased
a-SMA by approximately 1.8-fold compared with the
levels in Kitþ /þ mice (Figure 5), a shift that is consistent
with tubular EMT.22 UUO kidneys from MC-reconstituted
KitW/KitWv mice had preserved E-cadherin expression and
inhibited a-SMA induction compared with UUO kidneys
from KitW/KitWv mice (Figure 5). This suggests that MCs
decrease the occurrence of tubular EMT, a key event in the
pathogenesis of renal interstitial fibrosis.
The effect of MCs in cytokine expression after UUO
Cytokines released from infiltrated monocytes/macrophages
or T cells have been implicated in kidney inflammation in the
UUO model.23 To evaluate changes in the expression profiles
of cytokines in kidney, we used LINCOplex to measure the
kidney tissue levels of monocyte chemoattractant protein
(MCP)-1, interferon (IFN)-g, and interleukin (IL)-10 in
kidneys from Kitþ /þ , KitW/KitWv, and MC-reconstituted
KitW/KitWv mice 3 weeks after ureteral obstruction.
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Figure 3 | MCs decrease the number of infiltrating ERHR3- and CD3-positive cells in UUO kidneys. Representative light micrographs of
ERHR3 staining (a–d, arrows) and CD3 staining (e–h, open arrows); the sections were cut from kidneys taken from sham-operated, Kitþ /þ ,
KitW/KitWv, and MC-reconstituted KitW/KitWv mice 3 weeks after surgery and are counterstained with hematoxylin. Bar¼ 50 mm. The
number of infiltrating ERHR3-positive cells (i) and CD3-positive cells (j) in the sham-operated and UUO kidneys at 1, 2, and 3 weeks after
surgery; n¼ 6–8 for each experimental group. Data are expressed as means±s.d. *Po0.025 compared with UUO kidneys from Kitþ /þ mice;
**Po0.01 compared with UUO kidneys from Kitþ /þ mice; wPo0.025 compared with UUO kidneys from KitW/KitWv mice; zPo0.01
compared with UUO kidneys from KitW/KitWv mice. Kitþ /þ , congenic wild-type WBB6F1-Kit
þ /þ mice; KitW/KitWv, MC-deficient
WBB6F1-Kit
W/KitWv mice; Sham, sham-operated mice.
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However, there were no significant differences in MCP-1,
IFN-g, or IL-10 between kidneys from Kitþ /þ and KitW/
KitWv mice (data not shown).
DISCUSSION
Conflicting data have been published about the antifibrotic
effect of MCs in a renal fibrosis model. In this study, we
showed that MCs decrease interstitial renal fibrosis in a UUO
mouse model. The evidence that MCs have an antifibrotic
effect is that renal fibrosis, shown with Masson’s trichrome
stain, and collagen type I deposits in obstructed kidneys were
more extensive in MC-deficient KitW/KitWv mice than in
Kitþ /þ control mice (Figure 2). Reconstitution of MCs in
KitW/KitWv mice resulted in less interstitial fibrosis and
collagen type 1 deposition into the obstructed kidneys.
Furthermore, we found that MCs protect against renal
structural damage in obstructed kidneys. The obstructed
kidneys of KitW/KitWv mice showed relatively more damage
to the renal tubular structure than the obstructed Kitþ /þ
kidneys (Figure 1c). The obstructed kidneys of MC-
reconstituted KitW/KitWv mice showed fewer destructive
changes to the renal tubular structure and less stromal
fibrosis and stromal inflammatory cell infiltration than those
in KitW/KitWv mice.
Because TGF-b1 is the main mediator of fibrosis, the
origin of the TGF-b1 causing renal fibrosis in the UUO
model is important. It has been shown that infiltrating
inflammatory cells, such as monocytes/macrophages, may
release cytokines such as TGF-b1 that can induce collagen
synthesis by fibroblasts and cause further fibrosis.24 Support-
ing this, decreased interstitial macrophage infiltration
correlates with reduced tubulointerstitial fibrosis in the
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Figure 4 | Effect of MCs on TGF-b1 tissue levels and TGF-b1-induced Smad 2/3 and Smad 7 in UUO and sham-operated kidneys.
(a) TGF-b1 mRNA levels in sham-operated or UUO kidneys 3 weeks after the operation as determined by real-time PCR. Results were similar
in three independent experiments. (b) The tissue level of activated TGF-b1 was quantified by enzyme-linked immunosorbent assay
in sham-operated or UUO kidneys 3 weeks after surgery. Results were similar in three independent experiments. (c–d) Immunoblot analyses
of Smad 2/3 (c) and Smad 7 (d) in UUO kidneys. Blots were probed with Smad 2/3 or Smad 7 antibodies. The membrane was stripped
and reprobed with an anti-actin antibody to verify equal protein loading. Results were similar in three independent experiments.
Densitometric analyses are presented below the blots as the relative ratio of Smad 2/3 or Smad 7 to actin. The relative ratio measured in
sham-operated kidneys is arbitrarily presented as 1. Data are expressed as mean±s.d. *Po0.025 compared with UUO kidneys from Kitþ /þ
mice; wPo0.025 compared with UUO kidneys from KitW/KitWv mice. Kitþ /þ , congenic wild-type WBB6F1-Kitþ /þ mice; KitW/KitWv, MC-
deficient WBB6F1-Kit
W/KitWv mice; Sham, sham-operated mice.
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UUO model.25 Our data show that MCs decrease both the
infiltration of ERHR3-positive macrophages and the tissue
levels of TGF-b1 in obstructed kidney (Figure 3). Therefore,
these data suggest that MCs may decrease the production of
TGF-b1 and its release from ERHR3-positive macrophages in
the UUO model.
MCs produce and release several chemical mediators.26
Some of these mediators can modulate biological responses
by regulating cytokine expression or inflammatory cell
infiltration.27 Timoshanko et al.9 measured renal mRNA
levels of chemokines such as RANTES (regulated upon
activation, normal T cell, expressed, and secreted), macro-
phage inflammatory proteins, MCP-1, and IFN-inducible
protein-10 in wild-type mice and MC-deficient mice in the
crescentic glomerulonephritis model and suggested that MCs
aggravate crescentic glomerulonephritis by regulating the
intercellular adhesion molecule (ICAM)-1 and P-selectin
expression in kidney. Miyazawa et al.28 found that MC-deficient
mice expressed higher levels of TGF-b1 mRNA than wild-
type mice in the chronic glomerular disease model, whereas
IL-10 and IFN-g mRNA levels did not differ significantly
between MC-deficient and wild-type mice. They therefore
suggested that MCs may have a protective role in this model.
We similarly showed that there were no significant differences
in MCP-1, IFN-g, and IL-10 in kidney between Kitþ /þ and
KitW/KitWv mice, and our data also showed that MCs
decrease the tissue levels of TGF-b1 in obstructed kidneys
from Kitþ /þ and MC-reconstituted KitW/KitWv mice.
These results suggest that MCs may downregulate TGF-b1
expression in models of chronic glomerular disease or renal
fibrosis.
Because TGF-b1 is the main inducer of EMT, the increased
expression of TGF-b1 in the obstructed kidneys could be
involved in the loss of the epithelial phenotype and the
acquisition of the mesenchymal phenotype. Our data show
that obstructed kidneys in Kitþ /þ mice express less E-
cadherin and more a-SMA than the kidneys of sham-
operated mice, and this suppression of E-cadherin and
induction of a-SMA is greater in the kidneys of KitW/KitWv
mice than in those of Kitþ /þ mice. Reconstitution of MCs in
KitW/KitWv mice preserved E-cadherin expression and
inhibited a-SMA induction in UUO kidneys. Therefore, the
regulation of MCs might decrease the effect of EMT in
ureteral obstruction.
Another controversial aspect of the role of MCs in kidney
disease is whether there are MCs in kidney. Hochegger et al.4
have detected MCs not in kidney but in regional lymph nodes
in the anti-glomerular basement membrane glomerulone-
phritis model and suggested that MCs can regulate
inflammatory responses in regional lymph nodes. In this
study, we found that MCs are located in the UUO kidney
from Kitþ /þ and MC-reconstituted KitW/KitWv mice. Thus,
MCs in the kidney may regulate the renal inflammatory
response in the UUO model.
All of these data from the UUO model suggest that MCs
have a protective role in interstitial fibrosis, but future studies
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Figure 5 | Immunoblotting analyses for E-cadherin and a-SMA. E-cadherin expression (a) was significantly decreased and a-SMA
expression (b) was significantly increased in KitW/KitWv kidneys compared with Kitþ /þ kidneys. In contrast, reconstitution of MCs in
KitW/KitWv mice preserved E-cadherin expression and inhibited a-SMA induction in the obstructed kidney compared with UUO kidneys
from KitW/KitWv mice. The relative ratio measured in sham-operated kidneys is arbitrarily presented as 1. Data are expressed as
mean±s.d. *Po0.025 compared with UUO kidneys from Kitþ /þ mice; wPo0.025 compared with UUO kidneys from KitW/KitWv mice.
Kitþ /þ , congenic wild-type WBB6F1-Kit
þ /þ mice; KitW/KitWv, MC-deficient WBB6F1-Kit
W/KitWv mice; Sham, sham-operated mice.
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will be needed to investigate whether MCs can be used
therapeutically for the treatment of renal disease.
MATERIALS AND METHODS
Animal experiments: UUO model
Our animal studies were reviewed and approved by the Institutional
Animal Care and Use Committee of Chonbuk National University
Medical School. Genetically MC-deficient KitW/KitWv mice and
Kitþ /þ mice were purchased from The Jackson Laboratory (Bar
Harbor, ME, USA). Male Kitþ /þ mice (20–30 g body weight, n¼ 8),
KitW/KitWv mice (20–30 g body weight, n¼ 7), and MC-reconstituted
KitW/KitWv mice (20–30 g body weight, n¼ 6) were used in these
experiments. In mice anesthetized with ketamine (100 mg/kg) and
xylazine (10 mg/kg), renal interstitial fibrosis was induced as previously
described.29 Briefly, an incision was made in the midline of the
abdomen, and the left proximal ureter was exposed and was ligated at
two separate locations using 3–0 silk. In sham-operated Kitþ /þ mice,
the ureters were exposed and manipulated but not ligated. In
preliminary experiments, we examined the renal cortex 1, 3, and 5
weeks after UUO. Because the histopathological score (described
below) was most appropriate for assessing renal fibrosis at 3 weeks after
ureteral obstruction, we evaluated the effects of UUO at this time.
Three weeks after UUO, the mice were killed and the unilaterally
obstructed kidney was harvested and cut in half. One half was fixed in
formalin for subsequent immunohistochemical staining, and the
remaining tissue was stored at 201C for subsequent protein isolation.
Reconstitution of MCs in MC-deficient KitW/KitWv mice
The MC deficiency of KitW/KitWv mice was systemically repaired as
described.30 Bone marrow cultured mast cells were obtained by
culturing bone marrow cells from femurs of wild-type Kitþ /þ mice
for 4–5 weeks in Dulbecco’s modified Eagle’s medium (Sigma
Chemical Co., St Louis, MO, USA) supplemented 20% with WEHI-
3-conditioned medium (containing IL-3); at this time over 95% of
the cells were identified as immature MCs by May–Grunwald–-
Giemsa staining. For MC reconstitution studies, bone marrow
cultured mast cells were transferred by tail-vein injection (1 107
cells in 200ml of Dulbecco’s modified Eagle’s medium) into MC-
deficient KitW/KitWv mice, and the recipients were used for
experiments 18 weeks later. MCs were identified in kidney by
toluidine blue staining
Histology and immunohistochemistry
Portions of sham-operated and UUO kidneys were fixed in 10%
neutral buffered formalin and embedded in paraffin. The tissue was
sectioned at 5 mm and stained with hematoxylin–eosin stain for light
microscopic analysis. The presence of interstitial fibrosis was
assessed in slides stained with Masson’s trichrome. Toluidine blue
staining was performed by immersing kidney sections in 0.1%
toluidine blue (Sigma Chemical Co.) for 5 min at room temperature.
MCs were quantified in 20 randomly selected kidney sections, and
the amount was expressed as the number of MCs in a  200
magnification field. Immunostaining for anti-tryptase (Abcam,
Cambridge, UK), anti-mouse type I collagen (SouthernBiotech,
Birmingham, AL, USA), anti-CD3 (Santa Cruz Biotechnology, Santa
Cruz, CA, USA), and anti-ERHR3 (BMA, Augst, Switzerland) was
also used to stain paraffin sections as described previously.29 Digital
images of the immunostaining were obtained with a Zeiss Z1
microscope (Carl Zeiss, Go¨ttingen, Germany). The area positive for
type I collagen was evaluated from the unit area ( 200
magnification field) and expressed as a percentage per unit area
using a digital image analysis program (AnalySIS, Soft Imaging
System, Mu¨nster, Germany).
Histopathological scoring
Histopathology was scored in the cortex by a scorer blinded to
treatment group. Tubular injury was assessed by grading tubular
dilatation, epithelial desquamation, and brush border loss in 10
randomly chosen, nonoverlapping fields ( 200 magnification)
using methods previously described.31 Briefly, the lesions were
graded on a scale from 0 to 4: 0¼ normal; 1¼mild, involvement of
less than 25% of the cortex; 2¼moderate, involvement of 25–50%
of the cortex; 3¼ severe, involvement of 50–75% of the cortex;
4¼ extensive damage involving more than 75% of the cortex.
Immunoblotting
Immunoblotting was performed as previously described.32 Primary
antibodies to Smad 2/3 and Smad 7 were purchased from Cell
Signaling Technology Inc. (Beverly, MA, USA). The antibody to
E-cadherin was purchased from BD Biosciences (Bedford, UK), and
those to actin and a-SMA were purchased from Sigma-Aldrich
(St Louis, MO, USA). Signals were analyzed by densitometric
scanning (LAS-3000; Fuji Film, Tokyo, Japan). Densitometric
analyses are presented as the ratio relative to actin.
Enzyme-linked immunosorbent assay of TGF-b1
The tissue concentrations of TGF-b1 in kidney were determined
using enzyme-linked immunosorbent assay kits (R&D Systems,
Minneapolis, MN, USA) 3 weeks after the UUO operation.29 In all
cases, a standard curve was constructed from the standards provided
by the manufacturer.
Real-time quantitative RT-PCR
Total RNA from each kidney sample was isolated using TRIzol
solution (GIBCO Invitrogen, Grand Island, NY, USA) and
quantified by the ratio of absorption at 260 nm to that at 280 nm.
For each sample, 1 mg of total RNA was reverse transcribed into first-
strand cDNA in a 20-ml reaction system (Roche Diagnostics,
Mannheim, Germany) at 551C for 30 min. Quantitative RT-PCR
analysis was performed with the Light-Cycler FastStart DNA Master
SYBR Green I (Roche Diagnostics). For real-time PCR, the following
primers were used: TGF-b1: forward, 50-GAGAGCCCTGGATAC
CAACTATTG-30; reverse, 50-GTGTGTCCAGGCTCCAAATATAG-30.
GAPDH (internal control): forward, 50-AGAACATCATCCCTG
CATCC-30; reverse, 50-CCTGCTTCACCACCTTCTTG-30.
Cytokine analysis
Tissue MCP-1, IFN-g, and IL-10 concentrations from kidney were
measured in triplicate by using a Mouse Cytokine Lincoplex kit
(Linco Research Inc., St Charles, MI, USA) 1, 2, and 3 weeks after
ureteral obstruction. Kidney from Kitþ /þ , KitW/KitWv and MC-
reconstituted KitW/KitWv mice were analyzed in the same assay. In
all cases, a standard curve was constructed from the standards
provided by the manufacturer.
Statistical analysis
Data are expressed as means±standard deviation. Mean compar-
isons between two groups were examined for significant differences
using the Mann–Whitney U-test, with Po0.025 indicating statistical
significance.
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